Give Your Patients An Early Advantage
NxGen’s Early Advantage Panel screens for 65 genetic conditions during or before pregnancy to give you the tools you need to provide your patients with the best care possible.
With the Early Advantage Panel, you can give your patients more pregnancy and birth plan options, shorten the diagnostic odyssey, and be ready to begin any necessary treatment right after birth.
What is the Early Advantage Panel?
Strengthening Newborn Screening
NBS is one of the most successful public health initiatives in the US. It is the nation’s largest genetic screening program and screens approximately 4 million infants every year. While NBS is an important part of neonatal care, it does have some limitations.
- The number of conditions screened for is inconsistent from state to state.
- NBS can be negatively impacted by several different factors such as birth weight, ethnicity, and time of sample collection that can lead to more false positives & false negatives.
- Results may be returned too late to begin treatments that are critical in the first few days of life.
As a doctor, when you know a child’s risk for a genetic condition before they are born, you can work with parents to come up with a birth and early care plan supplemented by targeted diagnostic testing.
NBS in the United States
Addressing Gaps in the Newborn Screening Program
NxGen's NatalCare Philosophy
NatalCare is NxGen’s curation philosophy for our carrier screening, NIPS, vaginosis, and urinary tract infection products which focuses on improving pregnancy and newborn outcomes.
Our innovative approach in designing the Early Advantage Panel lets us detect more at-risk pregnancies, increase prenatal and birth team choices, and facilitate faster diagnoses and earlier treatments for genetic conditions.
Contact a NxGen Representative
“Newborn Screening.” NORD (National Organization for Rare Disorders). 26 Jan. 2021. https://rarediseases.org/policy-issues/newborn-screening/